Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The overexpression of human apurinic/apyrimidinic (AP) endonuclease 1 (APE1/Ref-1), a key enzyme in the DNA base excision repair (BER) pathway, is often associated with tumor cell resistance to various anticancer drugs. In this study, we examined the molecular basis of transcriptional regulatory (nonrepair) function of APE1 in promoting resistance to certain types of drugs. We have recently shown that APE1 stably interacts with Y-box-binding protein 1 (YB-1), and acts as its coactivator for the expression of multidrug resistance gene MDR1, thereby causing drug resistance. In this study, we show, to the best of our knowledge, for the first time that APE1 is stably associated with the basic transcription factor RNA polymerase II (RNA pol II) and the coactivator p300 on the endogenous MDR1 promoter. The depletion of APE1 significantly reduces YB-1–p300 recruitment to the promoter, resulting in reduced RNA pol II loading. Drug-induced APE1 acetylation, which is mediated by p300, enhances formation of acetylated APE1 (AcAPE1)–YB-1–p300 complex on the MDR1 promoter. Enhanced recruitment of this complex increases MDR1 promoter-dependent luciferase activity and its endogenous expression. Using APE1-downregulated cells and cells overexpressing wild-type APE1 or its nonacetylable mutant, we have demonstrated that the loss of APE1's acetylation impaired MDR1 activation and sensitizes the cells to cisplatin or etoposide. We have thus established the basis for APE1's acetylation-dependent regulatory function in inducing MDR1-mediated drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536 · cited 4×
“…occurs due to enhanced expression of MDR1 and other ATP-binding cassette (ABC) transporter proteins in intrinsically drug-resistant cancer cells, as well as in many tumors that acquire drug resistance after chemotherapy (Ambudkar et al., 2005; Gottesman et al., 2002; Gottesman and Pastan, 1993).”
BackgroundInfluentialREPAIR OF OXIDATIVE DAMAGE TO DNA: Enzymology and Biology
Demple, B., & Harrison, L. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.004411 · Cited by 1,495
MUTAGENESIS BY APURINIC/APYRIMIDINIC SITES
Loeb, L. A., & Preston, B. D. (1986) · Annual Review of Genetics · doi:10.1146/annurev.ge.20.120186.001221 · Cited by 901
Xanthoudakis, S., & Curran, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05097.x · Cited by 708 · cited 2×
“APE1 was identified as a reductive activator of c-Jun in vitro and named redox effector factor-1 (Ref-1; Xanthoudakis and Curran, 1992) and was subsequently shown to activate several other transcription factors e.”
BackgroundExcision of Deoxyribose Phosphate Residues by DNA Polymerase β During DNA Repair
Matsumoto, Y., & Kim, K. (1995) · Science · doi:10.1126/science.7624801 · Cited by 683 · cited 2×
“…products generated in the genome either spontaneously or after excision of oxidized and alkylated bases by DNA glycosylases (Demple and Harrison, 1994; Doetsch and Cunningham, 1990; Fan and Wilson, 2005; Izumi et al., 2003; Matsumoto and Kim, 1995; Mitra et al., 2002; Singhal et al., 1995).”
BackgroundMechanisms of anti-cancer agents: Emphasis on oxidative stress and electron transfer
Kovacic, P., & Osuna Jr., J. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003401046 · Cited by 187
Ando, K., Hirao, S., Kabe, Y., Ogura, Y., Sato, I., Yamaguchi, Y., Wada, T., & Handa, H. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn416 · Cited by 155 · cited 2×
“, 1993); however, subsequent analyses showed that neither Cys65 nor other cysteine residues are involved in redox regulation (Ordway et al., 2003; Ando et al., 2008).”
Background
Cited by
Y-box-binding protein 1 (YB-1) and its functions
Eliseeva, I. A., Kim, E. R., Guryanov, S. G., Ovchinnikov, L. P., & Lyabin, D. N. (2011) · Biochemistry (Moscow) · doi:10.1134/s0006297911130049 · Cited by 389
Minimizing the damage: repair pathways keep mitochondrial DNA intact
Kazak, L., Reyes, A., & Holt, I. J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3439 · Cited by 388
YB ‐1 protein: functions and regulation
Lyabin, D. N., Eliseeva, I. A., & Ovchinnikov, L. P. (2014) · WIREs RNA · doi:10.1002/wrna.1200 · Cited by 381
Human Apurinic/Apyrimidinic Endonuclease 1
Li, M., & Wilson, D. M. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5492 · Cited by 255
Oxidative genome damage and its repair: implications in aging and neurodegenerative diseases
Hegde, M. L., Mantha, A. K., Hazra, T. K., Bhakat, K. K., Mitra, S., & Szczesny, B. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.01.005 · Cited by 141
“Recently, we have established the molecular basis of APE1’s acetylation-dependent regulatory function in inducing MDR1-mediated drug resistance (Sengupta et al., 2010).”
BackgroundSelf-citationVasquez, V., Mitra, J., Hegde, P. M., Pandey, A., Sengupta, S., Mitra, S., Rao, K. S., & Hegde, M. L. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170342 · Cited by 88
Self-citation
Metadata
- Authors
- Sengupta, S., Mantha, A. K., Mitra, S., & Bhakat, K. K.
- Venue
- Oncogene
- Published
- 2010-09-20
- Volume
- 30
- Issue
- 4
- Pages
- 482-493
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2086061446
- Cited by
- 119
- References
- 7
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.